Akèy › Kansè fwa
Etid klinik pou Kansè fwa ap rekrite nan Etazini
67 etid pou Kansè fwa ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Houston, TX14 etid
- Cleveland, OH11 etid
- Los Angeles, CA11 etid
- Dallas, TX10 etid
- Boston, MA9 etid
- Chicago, IL8 etid
- St. Louis, MO8 etid
- Philadelphia, PA7 etid
- Durham, NC7 etid
- New York City, NY6 etid
- Orange, CA6 etid
- Washington, DC6 etid
- Nashville, TN5 etid
- San Francisco, CA5 etid
- Baldwin Park, CA5 etid
- Seattle, WA5 etid
- Rochester, MN5 etid
- Pittsburgh, PA5 etid
- San Diego, CA4 etid
- Ann Arbor, MI4 etid
- Mountain View, CA4 etid
- Aurora, CO4 etid
- The Bronx, NY3 etid
- Columbus, OH3 etid
- Birmingham, AL3 etid
- Winston-Salem, NC3 etid
- Richmond, VA3 etid
- Baltimore, MD3 etid
- Santa Monica, CA3 etid
- Portland, OR3 etid
- Atlanta, GA3 etid
- San Antonio, TX3 etid
- Highlands Ranch, CO3 etid
- Kansas City, MO3 etid
- Omaha, NE3 etid
- Irvine, CA3 etid
- Miami, FL3 etid
- Tampa, FL3 etid
Pa eta
- Alabama3 etid
- Arizona5 etid
- Arkansas3 etid
- Colorado7 etid
- Connecticut3 etid
- Florid10 etid
- Georgia4 etid
- Illinois11 etid
- Kalifòni24 etid
- Kansas3 etid
- Maryland8 etid
- Massachusetts11 etid
- Michigan5 etid
- Minnesota9 etid
- Missouri11 etid
- Nebraska3 etid
- New York10 etid
- North Carolina11 etid
- Ohio15 etid
- Oklahoma3 etid
- Oregon3 etid
- Pennsylvania13 etid
- Tennessee6 etid
- Texas24 etid
- Utah3 etid
- Virginia7 etid
- Washington5 etid
- Wisconsin5 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07227012Collection of Blood From Patients With Cancer
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT00034216DESTINY-PANTUMOUR04
Ap rekriteEtid obsèvasyon
Laj 18 a 130 · Tout sèks · Mizajou Sep 25, 2026 · NCT07124000National Liver Cancer Screening Trial
Ap rekriteFaz 4
Laj 18 a 85 · Tout sèks · Mizajou Sep 25, 2026 · NCT06084234A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06858813Protoacoustic Imaging For 3D Mapping
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07832617A Study Evaluating a New Radiation Treatment Workflow (NGDS)
Ap rekrite
Laj 21 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07824583EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT06263088Histotripsy Plus Chemotherapy vs Chemotherapy Alone for Advanced Colorectal Liver Metastasis
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT07044362Defining the Ablative Dose for Y-90 TARE
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT07586046CREO - Microwave Ablation Feasibility Study
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07817147Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
Ap rekriteEtid obsèvasyon
Laj 22 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT06486454GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT04864054A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06440005Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
Ap rekriteEtid obsèvasyon
Laj 18 a 50 · Fanm · Mizajou Sep 2, 2026 · NCT06904365Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 99 · Tout sèks · Mizajou Aug 24, 2026 · NCT05517811HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver Cancer
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT06899152Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Aug 6, 2026 · NCT07010315Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
Ap rekriteFaz 1
Laj 1 a 21 · Tout sèks · Mizajou Aug 6, 2026 · NCT04715191Distance-Based Exercise to Preserve Function and Prevent Disability
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT07059884DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jul 21, 2026 · NCT07717437Jump: MR Simulation For Radiation Therapy Master Protocol
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 20, 2026 · NCT04545957Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 14, 2026 · NCT06580002Multi-analyte Blood Test Clinical Trial
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jul 10, 2026 · NCT05199259An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT06342414Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.